(Q73385349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

3

Schally AV

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

5

Bostwick DG

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Halmos G

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Arencibia JM

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Davis R

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Journal of Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

623-629

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

3 November 2019

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Growth-inhibitory actions of analogues of Luteinizing Hormone Releasing Hormone on tumor cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Rational use of agonists and antagonists of luteinizing hormone-releasing hormone (LH-RH) in the treatment of hormone-sensitive neoplasms and gynaecologic conditions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Screening for prostate cancer--necessity or nonsense?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Cancer statistics, 1998.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Prognostic factors in the pathological assessment of prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/S0022-5347(05)67947-5

Identifiers

DOI

10.1016/S0022-5347(05)67947-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10647698%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference